Amylyx Pharmaceuticals, Inc. (AMLX) by event type
AMLX moves most on analyst upgrades — a median of -1.85% at 30 minutes across 17 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the AMLX overview →
How AMLX reacts across 5 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 2,688 of 2,717 | 17 | -1.85% | 41% | 0.00% |
| Analyst downgrades 41 of 2,603 | 16 | +1.74% | 63% | +1.36% |
| Coverage initiations 2,069 of 2,283 | 22 | -0.85% | 32% | +1.78% |
| Rating reiterations 297 of 3,522 | 54 | +0.30% | 56% | -0.08% |
| Price-target raises 272 of 1,790 | 23 | +0.17% | 52% | -0.32% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 1 further class was observed with fewer than 10 measured events and is not published.
That’s how AMLX usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Coverage initiations → · Rating reiterations → · Price-target raises → · AMLX overview →